Morgan Stanley »

Briacell Therapeutics Corp shares owned by Morgan Stanley

Quarter-by-quarter ownership of Briacell Therapeutics Corp (BCTX) shares owned by Morgan Stanley from 13F filings

Historical chart of Morgan Stanley investment in Briacell Therapeutics Corp

Tip: Access up to 7 years of quarterly data

All positions including Briacell Therapeutics Corp held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Briacell Therapeutics Corp by Morgan Stanley

Quarter filed Position value Share count Share price at filing
2024-03-31 $68k 24k 2.86
2023-09-30 $594k 95k 6.25

More positions owned by Morgan Stanley

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Alphabet Cap Stk Cl A (GOOGL)
Meta Platforms Cl A (META)
Visa Com Cl A (V)
JPMorgan Chase & Co. (JPM)
Alphabet Cap Stk Cl C (GOOG)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Eli Lilly & Co. (LLY)
Ishares Tr Core S&p500 Etf (IVV)
UnitedHealth (UNH)

View all positions for Morgan Stanley

Top funds holding Briacell Therapeutics Corp

Lynwood Capital Management
Susquehanna International
Bank Of Montreal
Redmond Asset Management
K.J. Harrison & Partners
Caption Management
Onyx Bridge Wealth Group
Citadel Advisors
Summit Trail Advisors
Morgan Stanley
Bank of America Corporation
HighTower Advisors
TD Waterhouse Canada
Concord Wealth Partners
National Bank Of Canada /fi/

View all funds holding Briacell Therapeutics Corp